๐
Blenrep
belantamab mafodotin
Multiple Myeloma
โน๏ธ Expired
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-CD38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/blenrep1